Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
63.6M
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
47.7M
-
Shares change
-
+675K
-
Total reported value, excl. options
-
$623M
-
Value change
-
+$5.07M
-
Put/Call ratio
-
0
-
Number of buys
-
32
-
Number of sells
-
-44
-
Price
-
$13.06
Significant Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q3 2021
110 filings reported holding RYTM - RHYTHM PHARMACEUTICALS, INC. - COM as of Q3 2021.
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.7M shares
of 63.6M outstanding shares and own 75.03% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (6.18M shares), NEA Management Company, LLC (4.91M shares), RA CAPITAL MANAGEMENT, L.P. (4.87M shares), BAKER BROS. ADVISORS LP (3.86M shares), BlackRock Inc. (3.36M shares), JANUS HENDERSON GROUP PLC (3.18M shares), FEDERATED HERMES, INC. (3.01M shares), GOLDMAN SACHS GROUP INC (2.91M shares), VANGUARD GROUP INC (2.31M shares), and STATE STREET CORP (2.22M shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.